Caley Castelein is Director at ViewRay, Inc. (VRAY). They have made 5 open-market trades across 4 companies since 2017, most recently 2026-05-14.
CIK 0001355758
4 open-market purchases totalling $12.7M since 2017, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TRML | 515,997 | $24.8M |
| ARPO | 295,414 | $9.7M |
| AADI | 2,165,998 | $4.4M |
| WHWK | 274,796 | $789K |
| NEOS | 653,114 | $751K |
| VRAY | 99,047 | $2K |
| PrivateUnlisted | 1,611,408 | — |
| Total | $40.5M |
Shares reported on the most recent Form 4, priced at the 2026-05-18 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TRML | BUY | 2023-10-25 | 2023-10-27 | $14.03 | $281K | +2.9% | +27.2% | +156.8% |
| VRAY | SELL | 2023-07-19 | 2023-07-21 | $0.07 | $272K | N/A | N/A | N/A |
| VRAY | BUY | 2022-05-10 | 2022-05-12 | $2.55 | $3.6M | -5.3% | -12.2% | +14.5% |
| AADI | BUY | 2021-08-26 | 2021-08-30 | $13.08 | $6.8M | +9.4% | +16.0% | -13.6% |
| PrivateAerpio Pharmaceuticals, Inc. | BUY | 2017-03-15 | 2017-03-17 | $5.00 | $2.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.